OverviewChartNewsTraderScreen

BVT Aktienanleihe SNW 18.12.2024/  DE000VM6K980  /

Frankfurt Zert./VONT
05/11/2024  10:33:09 Chg.-0.020 Bid12:22:40 Ask12:22:40 Underlying Strike price Expiration date Option type
100.510EUR -0.02% -
Bid Size: -		 -
Ask Size: -		 SANOFI SA INHABER ... 86.50 - 18/12/2024 Call
TeleTrader 25/10 Europe closes mixed amid earnings, data
TeleTrader 25/10 Europe lower in premarket as financial results pour in
TeleTrader 25/10 Sanofi's Q3 net sales up by 15.7% to €13.44 billion
TeleTrader 21/10 Sanofi in talks with CD&R for 50% stake in Opella
GlobeNewswire 02/09 Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire 26/08 Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...
GlobeNewswire 14/08 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire 13/08 Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 12/08 MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter ...
GlobeNewswire 12/08 MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi
GlobeNewswire 08/08 Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free sur...
GlobeNewswire 06/08 Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D ...
GlobeNewswire 05/08 Fierce Biotech Names Recludix Pharma a “Fierce 15” Biotech Company of 2024
GlobeNewswire 02/08 Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
GlobeNewswire 01/08 Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 01/08 Regeneron Reports Second Quarter 2024 Financial and Operating Results
GlobeNewswire 31/07 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2...
GlobeNewswire 25/07 Press Release: Online availability of Sanofi’s half-year financial report for 2024
TeleTrader 25/07 Europe lower premarket as earnings pour in
TeleTrader 25/07 Sanofi net sales up 7.8% to €10.7B in Q2
GlobeNewswire 25/07 Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded
GlobeNewswire 24/07 US Hematologists Express High Unmet Need in Treatments for Warm Autoimmune Hemolytic Anemia and Cold...
GlobeNewswire 18/07 Takeda’s Eohilia Sees Strong Early Adoption and Growth Potential in Eosinophilic Esophagitis, Accord...
GlobeNewswire 17/07 Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transfor...
GlobeNewswire 12/07 FluGen’s Intranasal M2SR Flu Vaccine, Co-Administered with High Dose Vaccine, in Older Adults Shows ...